Moors & Cabot, Inc.
Position in CRL — Charles River Laboratories International, Inc.
CIK 1607239
BOSTON, MA
Position in CRL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$392,573
+$99,841 QoQ
Shares Held
1,731
+2.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#331
of 564 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Derivatives in CRL
reported options exposure · as of Dec 31, 2021CallValue
$1,507
CallShares
4
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $18,215,220 across 9 Diagnostics & Research names. CRL ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QGEN |
Qiagen N.V.
|
339,461 | $13,272,925 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
2,681 | $1,344,146 | |
| 3 | ILMN |
Illumina, Inc.
|
5,000 | $879,150 | |
| 4 | WAT |
Waters Corp /De/
|
2,019 | $757,205 | |
| 5 | DHR |
Danaher Corp /De/
|
3,437 | $654,679 | |
| 6 | DGX |
Quest Diagnostics Inc
|
1,984 | $420,508 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
This page
|
1,731 | $392,573 | |
| 8 | RVTY |
Revvity, Inc.
|
2,375 | $264,242 |
All Filings in CRL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $392,573 | 1,731 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $292,732 | 1,697 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $336,123 | 1,685 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $263,635 | 1,685 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $255,665 | 1,685 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $272,591 | 1,811 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $334,864 | 1,814 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $355,530 | 1,805 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $412,127 | 1,995 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $535,668 | 1,977 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $538,046 | 2,276 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $447,030 | 2,281 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $495,138 | 2,355 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $453,489 | 2,247 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $485,699 | 2,229 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $420,955 | 2,139 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $425,372 | 1,988 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $536,135 | 1,888 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,507 | 4 | Call | Sole | 2022-02-14 | |
| 2021-12-31 | $715,128 | 1,898 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $741,980 | 1,798 | Shares | Sole | 2021-12-08 | |
| No filing history on record for this holder in this stock. | ||||||